-
Something wrong with this record ?
Modely in vitro - in vivo ve vývoji léčiv
[In vitro - in vivo models in drug development]
D. Vetchý, M. Kopecká, M. Vetchá, A. Franc
Language Czech Country Czech Republic
Document type Research Support, Non-U.S. Gov't
- Keywords
- in vitro - in vivo,
- MeSH
- Absorption MeSH
- Administration, Oral * MeSH
- Biopharmaceutics * classification standards MeSH
- Biological Availability MeSH
- Economics, Pharmaceutical trends MeSH
- Pharmacokinetics * MeSH
- Drug Therapy trends MeSH
- Drug Evaluation MeSH
- Pharmaceutical Preparations classification metabolism MeSH
- Delayed-Action Preparations * pharmacokinetics MeSH
- Humans MeSH
- Metabolic Clearance Rate MeSH
- Solubility * MeSH
- Drug Approval MeSH
- Models, Statistical * MeSH
- In Vitro Techniques MeSH
- Therapeutic Equivalency MeSH
- Research MeSH
- Check Tag
- Humans MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
Many experiments were performed to obtain in vitro in vivo correlations for different drugs and formulations. Most of the correlations involve orally administered medical forms and those with prolonged release of the drug. Most of the informative and recommendable in vitro in vivo correlations are those at level A. If the correlation is not possible, a multiple correlation at level C is performed, then those at levels C and B and finally the correlation at level D. The drug dissolution data correlate well with those of drug absorption in the case of establishing the correlation at level A. Although many correlations at levels B and C were weak, good correlations could be also obtained. For immediate release preparations, correlation at level A is recommended. Correlations at level C are appropriate providing especially for preparations with immediate release of the drug, where it is difficult to establish a correlation at level A. Multiple correlations at level C are acceptable and comparable with those at level A IVIVC, but are not suitable for products with immediate release of the drug.
In vitro - in vivo models in drug development
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14048020
- 003
- CZ-PrNML
- 005
- 20140415101909.0
- 007
- ta
- 008
- 140304s2014 xr d f 000 0cze||
- 009
- AR
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Vetchý, David, $d 1972- $7 mzk2006368163 $u a Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences, Brno
- 245 10
- $a Modely in vitro - in vivo ve vývoji léčiv / $c D. Vetchý, M. Kopecká, M. Vetchá, A. Franc
- 246 31
- $a In vitro - in vivo models in drug development
- 504 __
- $a Literatura
- 520 9_
- $a Many experiments were performed to obtain in vitro in vivo correlations for different drugs and formulations. Most of the correlations involve orally administered medical forms and those with prolonged release of the drug. Most of the informative and recommendable in vitro in vivo correlations are those at level A. If the correlation is not possible, a multiple correlation at level C is performed, then those at levels C and B and finally the correlation at level D. The drug dissolution data correlate well with those of drug absorption in the case of establishing the correlation at level A. Although many correlations at levels B and C were weak, good correlations could be also obtained. For immediate release preparations, correlation at level A is recommended. Correlations at level C are appropriate providing especially for preparations with immediate release of the drug, where it is difficult to establish a correlation at level A. Multiple correlations at level C are acceptable and comparable with those at level A IVIVC, but are not suitable for products with immediate release of the drug.
- 650 _2
- $a ekonomika farmaceutická $x trendy $7 D017850
- 650 12
- $a biofarmacie $x klasifikace $x normy $7 D001702
- 650 _2
- $a farmakoterapie $x trendy $7 D004358
- 650 12
- $a rozpustnost $7 D012995
- 650 12
- $a aplikace orální $7 D000284
- 650 12
- $a statistické modely $7 D015233
- 650 12
- $a léky s prodlouženým účinkem $x farmakokinetika $7 D003692
- 650 12
- $a farmakokinetika $7 D010599
- 650 _2
- $a biologická dostupnost $7 D001682
- 650 _2
- $a terapeutická ekvivalence $7 D013810
- 650 _2
- $a léčivé přípravky $x klasifikace $x metabolismus $7 D004364
- 650 _2
- $a metabolická clearance $7 D008657
- 650 _2
- $a absorpce $7 D000042
- 650 _2
- $a hodnocení léčiv $7 D004341
- 650 _2
- $a výzkum $7 D012106
- 650 _2
- $a schvalování léčiv $7 D017277
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a techniky in vitro $7 D066298
- 653 00
- $a in vitro - in vivo
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kopecká, Marie, $d 1943- $7 jx20050105014 $u Pharmacy, Policlinic, Svitavy
- 700 1_
- $a Vetchá, Martina $7 xx0273605 $u Pharmacy, Brno
- 700 1_
- $a Franc, Aleš $7 mzk2008479726 $u Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences, Brno
- 773 0_
- $t Chemické listy $x 0009-2770 $g Roč. 108, č. 1 (2014), s. 32-39 $w MED00011010
- 856 41
- $u http://www.chemicke-listy.cz/ojs3/index.php/chemicke-listy/article/view/569/569 $y domovská stránka časopisu - plný text volně přístupný
- 910 __
- $a ABA008 $b B 1918 $c 395 $z 0 $y 4
- 990 __
- $a 20140304133814 $b ABA008
- 991 __
- $a 20140415102006 $b ABA008
- 999 __
- $a ok $b bmc $g 1015063 $s 846573
- BAS __
- $a 3
- BMC __
- $a 2014 $b 108 $c 1 $d 32-39 $i 0009-2770 $m Chemické listy $n Chem. Listy $x MED00011010
- LZP __
- $c NLK137 $d 20140404 $a NLK 2014-13/dk